The wonders of 2-deoxy-d-glucose

IUBMB Life

Volumn 66, Issue 2, 2014, Pages 110-121

  Xi, Haibin ^a   Kurtoglu, Metin ^b   Lampidis, Theodore J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

2 deoxy d glucose; apoptosis; autophagy; endoplasmic reticulum stress; glycosylation; hypoxia; viral replication

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; BH3 PROTEIN; DEOXYGLUCOSE; FLUORODEOXYGLUCOSE; FRUCTOSE 6 PHOSPHATE; GLUCOSE; GLUCOSE 6 PHOSPHATE; GLUCOSE TRANSPORTER; HEXOKINASE; HYDROGEN; HYDROXYL GROUP; INITIATION FACTOR 2ALPHA; LIPOOLIGOSACCHARIDE; MANNOSE; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE; PENICILLIN DERIVATIVE; PROTEIN BCL 2; RHODAMINE 123;

APOPTOSIS; AUTOPHAGY; CARCINOMA CELL; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; EPILEPSY; GLUCOSE METABOLISM; GLYCOSYLATION; HUMAN; HYPOXIA; IMMUNE SYSTEM; IN VITRO STUDY; MITOCHONDRIAL RESPIRATION; MORBIDITY; NEOPLASM; NONHUMAN; PANCREAS CANCER; PENTOSE PHOSPHATE CYCLE; POSITRON EMISSION TOMOGRAPHY; PROKARYOTIC CELL; PROTEIN FOLDING; PROTEIN SYNTHESIS; REVIEW; RHABDOMYOSARCOMA; TRANSCRIPTION INITIATION; VIRUS INFECTION; VIRUS REPLICATION;

2-DEOXY-D-GLUCOSE; APOPTOSIS; AUTOPHAGY; ENDOPLASMIC RETICULUM STRESS; GLYCOSYLATION; HYPOXIA; VIRAL REPLICATION;

ANOXIA; APOPTOSIS; AUTOPHAGY; DEOXYGLUCOSE; ENDOPLASMIC RETICULUM STRESS; GLYCOSYLATION; HUMANS; NEOPLASMS; VIRUS REPLICATION;

EID: 84896388484     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1251     Document Type: Review

References (103)

1. Warburg, O., Wind, F., and, Negelein, E., (1927) The metabolism of tumors in the body. J. Gen. Physiol. 8, 519-530.
2. Kurtoglu, M., Gao, N., Shang, J., Maher, J. C., Lehrman, M. A., et al. (2007) Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation. Mol. Cancer Ther. 6, 3049-3058.
3. Kurtoglu, M., Maher, J. C., and, Lampidis, T. J., (2007) Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells. Antioxid. Redox Signal. 9, 1383-1390.
4. Xi, H., Kurtoglu, M., Liu, H., Wangpaichitr, M., You, M., et al. (2011) 2-deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion. Cancer Chemother. Pharmacol. 67, 899-910.
5. El Mjiyad, N., Caro-Maldonado, A., Ramirez-Peinado, S., and, Munoz-Pinedo, C., (2011) Sugar-free approaches to cancer cell killing. Oncogene 30, 253-264.
6. Liu, H., Hu, Y. P., Savaraj, N., Priebe, W., and, Lampidis, T. J., (2001) Hypersensitization of tumor cells to glycolytic inhibitors. Biochemistry 40, 5542-5547.
7. Liu, H., Savaraj, N., Priebe, W., and, Lampidis, T. J., (2002) Hypoxia increases tumor cell sensitivity to glycolytic inhibitors: a strategy for solid tumor therapy (model C). Biochem. Pharmacol. 64, 1745-1751.
8. Kurtoglu, M., and, Lampidis, T. J., (2009) From delocalized lipophilic cations to hypoxia: blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors. Mol. Nutr. Food Res. 53, 68-75.
9. Tsai, Y. P., and, Wu, K. J., (2012) Hypoxia-regulated target genes implicated in tumor metastasis. J. Biomed. Sci. 19, 102-0127-19-102.
10. Lampidis, T. J., Bernal, S. D., Summerhayes, I. C., and, Chen, L. B., (1983) Selective toxicity of rhodamine 123 in carcinoma cells in vitro. Cancer Res. 43, 716-720.
11. Bernal, S. D., Lampidis, T. J., McIsaac, R. M., and, Chen, L. B., (1983) Anticarcinoma activity in vivo of rhodamine 123, a mitochondrial-specific dye. Science 222, 169-172.
12. Jain, V. K., Kalia, V. K., Sharma, R., Maharajan, V., and, Menon, M., (1985) Effects of 2-deoxy-D-glucose on glycolysis, proliferation kinetics and radiation response of human cancer cells. Int. J. Radiat. Oncol. Biol. Phys. 11, 943-950.
13. Dwarakanath, B. S., and, Jain, V. K., (1987) Modification of the radiation induced damage by 2-deoxy-D-glucose in organ cultures of human cerebral gliomas. Int. J. Radiat. Oncol. Biol. Phys. 13, 741-746.
14. Mohanti, B. K., Rath, G. K., Anantha, N., Kannan, V., Das, B. S., et al. (1996) Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int. J. Radiat. Oncol. Biol. Phys. 35, 103-111.
15. Landau, B. R., Laszlo, J., Stengle, J., and, Burk, D., (1958) Certain metabolic and pharmacologic effects in cancer patients given infusions of 2-deoxy-D-glucose. J. Natl. Cancer Inst. 21, 485-494.
16. Nirenberg, M. W., and, Hogg, J. F., (1958) Inhibition of anaerobic glycolysis in ehrlich ascites tumor cells by 2-deoxy-D-glucose. Cancer Res. 18, 518-521.
17. Laszlo, J., Humphreys, S. R., and, Goldin, A., (1960) Effects of glucose analogues (2-deoxy-D-glucose, 2-deoxy-D-galactose) on experimental tumors. J. Natl. Cancer Inst. 24, 267-281.
18. Kern, K. A., and, Norton, J A., (1987) Inhibition of established rat fibrosarcoma growth by the glucose antagonist 2-deoxy-D-glucose. Surgery 102, 380-385.
19. Kaplan, O., Navon, G., Lyon, R. C., Faustino, P. J., Straka, E. J., et al. (1990) Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism. Cancer Res. 50, 544-551.
20. Maher, J. C., Krishan, A., and, Lampidis, T. J., (2004) Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions. Cancer Chemother. Pharmacol. 53, 116-122.
21. Maschek, G., Savaraj, N., Priebe, W., Braunschweiger, P., Hamilton, K., et al. (2004) 2-Deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res. 64, 31-34.
22. Boutrid, H., Jockovich, M. E., Murray, T. G., Pina, Y., Feuer, W. J., et al. (2008) Targeting hypoxia, a novel treatment for advanced retinoblastoma. Invest. Ophthalmol. Vis. Sci. 49, 2799-2805.
23. Brown, J., (1962) Effects of 2-deoxyglucose on carbohydrate metablism: review of the literature and studies in the rat. Metabolism 11, 1098-1112.
24. Sols, A., and, Crane, R. K., (1954) Substrate specificity of brain hexokinase. J. Biol. Chem. 210, 581-595.
25. Wick, A. N., Drury, D. R., Nakada, H. I., and, Wolfe, J. B., (1957) Localization of the primary metabolic block produced by 2-deoxyglucose. J. Biol. Chem. 224, 963-969.
26. Chen, W., and, Gueron, M., (1992) The inhibition of bovine heart hexokinase by 2-deoxy-D-glucose-6-phosphate: characterization by 31P NMR and metabolic implications. Biochimie 74, 867-873.
27. Manuel y, Keenoy, B., Zahner, D., and, Malaisse, W. J., (1992) Dissociated effects of 2-deoxy-D-glucose on D-[2-3H]glucose and D-[5-3H]glucose conversion into 3HOH in rat erythrocytes. Biochem J. 288 (Pt 2), 433-438.
28. Tower, D. B., (1958) The effects of 2-deoxy-D-glucose on metabolism of slices of cerebral cortex incubated in vitro. J. Neurochem. 3, 185-205.
29. Lampidis, T. J., Kurtoglu, M., Maher, J. C., Liu, H., Krishan, A., et al. (2006) Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells". Cancer Chemother. Pharmacol. 58, 725-734.
30. Pina, Y., Houston, S. K., Murray, T. G., Koru-Sengul, T., Decatur, C., et al. (2012) Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors. Clin. Ophthalmol. 6, 817-830.
31. Schmidt, M. F., Schwarz, R. T., and, Scholtissek, C., (1974) Nucleoside-diphosphate derivatives of 2-deoxy-D-glucose in animal cells. Eur. J. Biochem. 49, 237-247.
32. Schmidt, M. F., Biely, P., Kratky, Z., and, Schwarz, R. T., (1978) Metabolism of 2-deoxy-2-fluoro-D-[3H]glucose and 2-deoxy-2-fluoro-D-[3H]mannose in yeast and chick-embryo cells. Eur. J. Biochem. 87, 55-68.
33. Datema, R., and, Schwarz, R. T., (1979) Interference with glycosylation of glycoproteins. Inhibition of formation of lipid-linked oligosaccharides in vivo. Biochem. J. 184, 113-123.
34. Datema, R., Schwarz, R. T., and, Jankowski, A. W., (1980) Fluoroglucose-inhibition of protein glycosylation in vivo. Inhibition of mannose and glucose incorporation into lipid-linked oligosaccharides. Eur. J. Biochem. 109, 331-341.
35. Datema, R., and, Schwarz, R. T., (1978) Formation of 2-deoxyglucose- containing lipid-linked oligosaccharides. Interference with glycosylation of glycoproteins. Eur. J. Biochem. 90, 505-516.
36. Ramirez-Peinado, S., Alcazar-Limones, F., Lagares-Tena, L., El Mjiyad, N., Caro-Maldonado, A., et al. (2011) 2-Deoxyglucose induces noxa-dependent apoptosis in alveolar rhabdomyosarcoma. Cancer Res. 71, 6796-6806.
37. Andresen, L., Skovbakke, S. L., Persson, G., Hagemann-Jensen, M., Hansen, K. A., et al. (2012) 2-Deoxy D-glucose prevents cell surface expression of NKG2D ligands through inhibition of N-linked glycosylation. J. Immunol. 188, 1847-1855.
38. Zagorodna, O., Martin, S. M., Rutkowski, D. T., Kuwana, T., Spitz, D. R., et al. (2012) 2-Deoxyglucose-induced toxicity is regulated by bcl-2 family members and is enhanced by antagonizing bcl-2 in lymphoma cell lines. Oncogene 31, 2738-2749.
39. Etchison, J. R., and, Freeze, H. H., (1997) Enzymatic assay of D-mannose in serum. Clin. Chem. 43, 533-538.
40. DeSalvo, J., Kuznetsov, J. N., Du, J., Leclerc, G. M., Leclerc, G. J., et al. (2012) Inhibition of akt potentiates 2-DG-induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia. Mol. Cancer Res. 10, 969-978.
41. Mihaylova, M. M., and, Shaw, R. J., (2011) The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 13, 1016-1023.
42. Liu, H., Kurtoglu, M., Cao, Y., Xi, H., Kumar, R., et al. (2013) Conversion of 2-deoxyglucose-induced growth inhibition to cell death in normoxic tumor cells. Cancer Chemother. Pharmacol. 72, 251-262.
43. Schroder, M., and, Kaufman, R. J., (2005) ER stress and the unfolded protein response. Mutat. Res. 569, 29-63.
44. Xi, H., Barredo, J. C., Merchan, J. R., and, Lampidis, T. J., (2013) Endoplasmic reticulum stress induced by 2-deoxyglucose but not glucose starvation activates AMPK through CaMKKbeta leading to autophagy. Biochem. Pharmacol. 85, 1463-1477.
45. Jin, H. O., Seo, S. K., Kim, Y. S., Woo, S. H., Lee, K. H., et al. (2011) TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1. Oncogene 30, 3792-3801.
46. Wek, R. C., Jiang, H. Y., and, Anthony, T. G., (2006) Coping with stress: EIF2 kinases and translational control. Biochem. Soc. Trans. 34, 7-11.
47. Lin, X., Zhang, F., Bradbury, C. M., Kaushal, A., Li, L., et al. (2003) 2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism. Cancer Res. 63, 3413-3417.
48. Coleman, M. C., Asbury, C. R., Daniels, D., Du, J., Aykin-Burns, N., et al. (2008) 2-Deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer. Free Radic. Biol. Med. 44, 322-331.
49. Simons, A. L., Mattson, D. M., Dornfeld, K., and, Spitz, D. R., (2009) Glucose deprivation-induced metabolic oxidative stress and cancer therapy. J. Cancer Res. Ther. 5 Suppl 1, S2-6.
50. Ferretti, A., Bozzi, A., Di Vito, M., Podo, F., and, Strom, R., (1992) 13C and 31P NMR studies of glucose and 2-deoxyglucose metabolism in normal and enzyme-deficient human erythrocytes. Clin. Chim. Acta 208, 39-61.
51. Le Goffe, C., Vallette, G., Charrier, L., Candelon, T., Bou-Hanna, C., et al. (2002) Metabolic control of resistance of human epithelial cells to H2O2 and NO stresses. Biochem. J. 364, 349-359.
52. Levine, B., and, Kroemer, G., (2008) Autophagy in the pathogenesis of disease. Cell 132, 27-42.
53. Mathew, R., Karantza-Wadsworth, V., and, White, E., (2007) Role of autophagy in cancer. Nat. Rev. Cancer 7, 961-967.
54. DiPaola, R. S., Dvorzhinski, D., Thalasila, A., Garikapaty, V., Doram, D., et al. (2008) Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy. Prostate 68, 1743-1752.
55. Wu, H., Zhu, H., Liu, D. X., Niu, T. K., Ren, X., et al. (2009) Silencing of elongation factor-2 kinase potentiates the effect of 2-deoxy-D-glucose against human glioma cells through blunting of autophagy. Cancer Res. 69, 2453-2460.
56. Stein, M., Lin, H., Jeyamohan, C., Dvorzhinski, D., Gounder, M., et al. (2010) Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies. Prostate 70, 1388-1394.
57. Buchakjian, M. R., and, Kornbluth, S., (2010) The engine driving the ship: metabolic steering of cell proliferation and death. Nat. Rev. Mol. Cell Biol. 11, 715-727.
58. Zong, W. X., Li, C., Hatzivassiliou, G., Lindsten, T., Yu, Q. C., et al. (2003) Bax and bak can localize to the endoplasmic reticulum to initiate apoptosis. J. Cell Biol. 162, 59-69.
59. Ramirez-Peinado, S., Leon-Annicchiarico, C. L., Galindo-Moreno, J., Iurlaro, R., Caro-Maldonado, A., et al. (2013) Glucose-starved cells do not engage in prosurvival autophagy. J. Biol. Chem. 288, 30387-30398.
60. Matsui, Y., Takagi, H., Qu, X., Abdellatif, M., Sakoda, H., et al. (2007) Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and beclin 1 in mediating autophagy. Circ. Res. 100, 914-922.
61. Liang, J., Shao, S. H., Xu, Z. X., Hennessy, B., Ding, Z., et al. (2007) The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat. Cell Biol. 9, 218-224.
62. Marambio, P., Toro, B., Sanhueza, C., Troncoso, R., Parra, V., et al. (2010) Glucose deprivation causes oxidative stress and stimulates aggresome formation and autophagy in cultured cardiac myocytes. Biochim. Biophys. Acta 1802, 509-518.
63. Kim, J., Kundu, M., Viollet, B., and, Guan, K. L., (2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132-141.
64. Ben Sahra, I., Laurent, K., Giuliano, S., Larbret, F., Ponzio, G., et al. (2010) Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. Cancer Res. 70, 2465-2475.
65. Plomp, P. J., Wolvetang, E. J., Groen, A. K., Meijer, A. J., Gordon, P. B., et al. (1987) Energy dependence of autophagic protein degradation in isolated rat hepatocytes. Eur. J. Biochem. 164, 197-203.
66. Plomp, P. J., Gordon, P. B., Meijer, A. J., Hoyvik, H., and, Seglen, P. O., (1989) Energy dependence of different steps in the autophagic-lysosomal pathway. J. Biol. Chem. 264, 6699-6704.
67. Schellens, J. P., Meijer, A. J., (1991) Energy depletion and autophagy. Cytochemical and biochemical studies in isolated rat hepatocytes. Histochem. J. 23, 460-466.
68. Maiuri, M. C., Zalckvar, E., Kimchi, A., and, Kroemer, G., (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 8, 741-752.
69. Shim, H., Chun, Y. S., Lewis, B. C., and, Dang, C. V., (1998) A unique glucose-dependent apoptotic pathway induced by c-myc. Proc. Natl. Acad. Sci. USA 95, 1511-1516.
70. Aft, R. L., Zhang, F. W., and, Gius, D., (2002) Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death. Br. J. Cancer 87, 805-812.
71. Zhang, X. D., Deslandes, E., Villedieu, M., Poulain, L., Duval, M., et al. (2006) Effect of 2-deoxy-D-glucose on various malignant cell lines in vitro. Anticancer Res. 26, 3561-3566.
72. Wangpaichitr, M., Savaraj, N., Maher, J., Kurtoglu, M., and, Lampidis, T. J., (2008) Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines. Mol. Cancer Ther. 7, 1506-1513.
73. Pradelli, L. A., Beneteau, M., Chauvin, C., Jacquin, M. A., Marchetti, S., et al. (2010) Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to mcl-1 block in translation. Oncogene 29, 1641-1652.
74. Sawai, H., and, Domae, N., (2011) Discrimination between primary necrosis and apoptosis by necrostatin-1 in annexin V-positive/propidium iodide-negative cells. Biochem. Biophys. Res. Commun. 411, 569-573.
75. Hacker, G., and, Weber, A., (2007) BH3-only proteins trigger cytochrome c release, but how? Arch. Biochem. Biophys. 462, 150-155.
76. Merino, D., Giam, M., Hughes, P. D., Siggs, O. M., Heger, K., et al. (2009) The role of BH3-only protein bim extends beyond inhibiting bcl-2-like prosurvival proteins. J. Cell Biol. 186, 355-362.
77. Lowman, X. H., McDonnell, M. A., Kosloske, A., Odumade, O. A., Jenness, C., et al. (2010) The proapoptotic function of noxa in human leukemia cells is regulated by the kinase Cdk5 and by glucose. Mol. Cell 40, 823-833.
78. Meynet, O., Zunino, B., Happo, L., Pradelli, L. A., Chiche, J., et al. (2013) Caloric restriction modulates mcl-1 expression and sensitizes lymphomas to BH3 mimetic in mice. Blood 122, 2402-2411.
79. Frenzel, A., Grespi, F., Chmelewskij, W., and, Villunger, A., (2009) Bcl2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis 14, 584-596.
80. Zhao, Y., Coloff, J. L., Ferguson, E. C., Jacobs, S. R., Cui, K., et al. (2008) Glucose metabolism attenuates p53 and puma-dependent cell death upon growth factor deprivation. J. Biol. Chem. 283, 36344-36353.
81. Yamaguchi, R., Janssen, E., Perkins, G., Ellisman, M., Kitada, S., et al. (2011) Efficient elimination of cancer cells by deoxyglucose-ABT-263/737 combination therapy. PLoS One 6, e24102.
82. Levesley, J., Steele, L., Taylor, C., Sinha, P., and, Lawler, S. E., (2013) ABT-263 enhances sensitivity to metformin and 2-deoxyglucose in pediatric glioma by promoting apoptotic cell death. PLoS One 8, e64051.
83. Leung, H. J., Duran, E. M., Kurtoglu, M., Andreansky, S., Lampidis, T. J., et al. (2012) Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits kaposi's sarcoma-associated herpesvirus replication and gene expression. Antimicrob. Agents Chemother. 56, 5794-5803.
84. Isler, J. A., Skalet, A. H., and, Alwine, J. C., (2005) Human cytomegalovirus infection activates and regulates the unfolded protein response. J. Virol. 79, 6890-6899.
85. Tirosh, B., Iwakoshi, N. N., Lilley, B. N., Lee, A. H., Glimcher, L. H., et al. (2005) Human cytomegalovirus protein US11 provokes an unfolded protein response that may facilitate the degradation of class I major histocompatibility complex products. J. Virol. 79, 2768-2779.
86. Merquiol, E., Uzi, D., Mueller, T., Goldenberg, D., Nahmias, Y., et al. (2011) HCV causes chronic endoplasmic reticulum stress leading to adaptation and interference with the unfolded protein response. PLoS One 6, e24660.
87. Child, S. J., Hakki, M., De Niro, K. L., and, Geballe, A. P., (2004) Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. J. Virol. 78, 197-205.
88. He, B., Gross, M., and, Roizman, B., (1997) The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 94, 843-848.
89. Mulvey, M., Arias, C., and, Mohr, I., (2007) Maintenance of endoplasmic reticulum (ER) homeostasis in herpes simplex virus type 1-infected cells through the association of a viral glycoprotein with PERK, a cellular ER stress sensor. J. Virol. 81, 3377-3390.
90. Delgado, T., Carroll, P. A., Punjabi, A. S., Margineantu, D., Hockenbery, D. M., et al. (2010) Induction of the warburg effect by kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. Proc. Natl. Acad. Sci. USA 107, 10696-10701.
91. Maehama, T., Patzelt, A., Lengert, M., Hutter, K. J., Kanazawa, K., et al. (1998) Selective down-regulation of human papillomavirus transcription by 2-deoxyglucose. Int. J. Cancer 76, 639-646.
92. Parkin, D. M., (2006) The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118, 3030-3044.
93. Folkman, J., (2006) Angiogenesis. Annu. Rev. Med. 57, 1-18.
94. Merchan, J. R., Kovacs, K., Railsback, J. W., Kurtoglu, M., Jing, Y., et al. (2010) Antiangiogenic activity of 2-deoxy-D-glucose. PLoS One 5, e13699.
95. De Bock, K., Georgiadou, M., Schoors, S., Kuchnio, A., Wong, B. W., et al. (2013) Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 154, 651-663.
96. Sottnik, J. L., Lori, J. C., Rose, B. J., and, Thamm, D. H., (2011) Glycolysis inhibition by 2-deoxy-D-glucose reverts the metastatic phenotype in vitro and in vivo. Clin. Exp. Metastasis 28, 865-875.
97. Keith, B., and, Simon, M. C., (2007) Hypoxia-inducible factors, stem cells, and cancer. Cell 129, 465-472.
98. Valastyan, S., and, Weinberg, R. A., (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275-292.
99. Bénéteau, M., Zunino, B., Jacquin, M. A., Meynet, O., Chiche, J., et al. (2012) Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response. Proc. Natl. Acad. Sci. USA 109, 20071-20076.
100. Andresen, L., Skovbakke, S. L., Persson, G., Hagemann-Jensen, M., Hansen, K. A., et al. (2012) 2-Deoxy D-glucose prevents cell surface expression of NKG2D ligands through inhibition of N-linked glycosylation. J. Immunol. 188, 1847-1855.
101. Raez, L. E., Papadopoulos, K., Ricart, A. D., Chiorean, E. G., Dipaola, R. S., et al. (2013) A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemother. Pharmacol. 71, 523-530.
102. Cardaci, S., Desideri, E., and, Ciriolo, M. R., (2012) Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug. J. Bioenerg. Biomembr. 44, 17-29.
103. Clem, B. F., O'Neal, J., Tapolsky, G., Clem, A. L., Imbert-Fernandez, Y., et al. (2013) Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer. Mol. Cancer Ther. 12, 1461-1470.